A person who has had a myocardial infarction often gets excellent emergency treatment at a hospital, and is able to go home or even return to work in a matter of days. Despite this quick recovery, all is not perfect, because the infarction stops blood and oxygen flow, which can quickly kill heart tissue. Unlike many other types of human tissue, heart tissue doesn’t regenerate, so heart function is compromised.
From Ant-Man to the Incredible Shrinking Machine, society has long envisioned developing devices tiny enough to enter human cells. Such nanotechnology could revolutionize the diagnosis of diseases like cancer and neurodegeneration, span new methods of precise drug delivery, and even directly repair damaged organs.
A biological pacemaker is one or more types of cellular components that, when implanted into certain regions of the heart, produce electrical stimuli that mimic that of the body’s natural pacemaker cells. Somatic gene transfer, cell fusion, or cell transplantation provide a way to realize it as somatic reprogramming strategies, which involve transfer of genes encoding transcription factors to transform working myocardium into a surrogate sinoatrial node, are furthest along in the possibilities.
Decades of clinical research studies have verified that mild electrical stimulation of the cranium does alleviate symptoms in a wide range of conditions.
We are in the midst of a demographic phenomenon known as the graying of society. In more affluent countries, the population is aging. According to the U.S. Census Bureau, the number of Americans aged 65 and older is projected to more than double by 2060.
We may well know how bad sleep deprivation is for us, but science is just starting to figure out why.
2019 was a revolutionary year in the field of chemistry as the Royal Swedish Academy of Sciences awarded the Nobel Prize in Chemistry 2018 to three brilliant chemists: Dr. Frances H. Arnold, Dr. George P. Smith, and Sir Gregory P. Winter.
The FHIR development community has expanded its scope to include the extraction of specific data abstracts from a patient’s chart and large datasets from electronic health record systems of even larger clinical data repositories.
Back in the mid-1960s, rotary-dial telephones were the norm, music cassette tapes were brand new, and microwave ovens hadn’t made it into houses yet. That’s also when newly minted electrical engineer Thomas Furness joined a U.S. Air Force Lab and began developing what would become
Say hello to Molly, Florence, and Ada—they’re just a few of the helpful, smart algorithm-powered chatbots taking their place in health care. Chatbots are computer programs designed to carry on a dialogue with people, assisting them via text messages, applications, or instant messaging. Essentially, instead